ADA 2025 - Team Care, Education and Early CGM Use in Type 2 Diabetes
Sponsored by 
Team Care, Education and Early CGM Use in Type 2 Diabetes
Event: American Diabetes Association (ADA) 85th Scientific Sessions
Location: Chicago, IL
Date: June 21, 2025
Speaker: Dr. Richard M. Bergenstal, Endocrinologist and Executive Director, International Diabetes Center, HealthPartners Institute
Session Overview:
In this 13-minute video from the ADA 85th Scientific Sessions, Dr. Bergenstal presents the first of three segments in the "Expanding the Dexcom Portfolio" session, exploring how continuous glucose monitoring (CGM) is reshaping diabetes care. Dr. Bergenstal outlines a stepwise path to innovation—from advanced sensor technology to clinical validation to real-world implementation.
Key Takeaways for Healthcare Providers:
- CGM as a standard of care: The ADA now recommends CGM for all individuals on insulin, recognizing it as a primary tool for assessing glycemic status beyond A1C.
- Expanding access: Dr. Bergenstal presents new data showing CGM benefits extend to people not on insulin, including those using GLP-1 therapies.
- Clinical integration: Resources from Dexcom and the International Diabetes Center support providers with tools to incorporate CGM into workflows, educate patients, and interpret data efficiently.
- Policy momentum: NCQA has begun incorporating CGM metrics into HEDIS measures, signaling broader systemic support.
- Call to action: The speaker urged earlier CGM adoption—even in prediabetes—and advocated for CGM and diabetes education to be foundational steps in treatment algorithms.
This session laid the groundwork for two additional presentations, Innovations in Dexcom Technology and Living Your Best Life with Lance Bass. Access the microsite and resources discussed in this presentation at dexcom.com/clinic-workflow.
Video Timestamps:
- [00:02] How CGM is Transforming Diabetes Care
- [02:04] 2025 Guidelines for Care
- [03:55] State of Type 2 Diabetes Report
- [05:28] Clinic Workflow: Getting Started with CGM
- [06:02] Resources for Patients and Providers
- [07:30] CGM & GLP-1 Use
- [09:39] CGM Use in Non-Insulin Therapy
- [10:03] Implementation Algorithm
This is a recording of a live presentation. The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.
The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.
MAT-10190